CeleCor Therapeutics – Candice Jenkins Consulting

Background

CeleCor Therapeutics is a biotechnology company pioneering innovation in prehospital heart attack treatment. Their lead drug, zalunfiban, is designed for emergency administration via injection, offering a critical intervention that improves patient survival before hospital arrival. To support investment, partnership, and acquisition efforts, CeleCor needed a professional, science-forward website to clearly communicate the drug’s clinical potential and establish credibility with biotech investors, cardiologists, and industry stakeholders.

Project Overview

Wondros was engaged to design and develop a targeted digital hub that positioned CeleCor as a leader in cardiac care innovation. The site needed to serve as a centralized resource for investors and medical professionals, offering clear, credible information supported by clinical data. The platform also needed to be easy to maintain, mobile-responsive, and aligned with CeleCor’s long-term growth strategy.

Project Goals

The objective was to create a targeted digital hub that:

Clearly conveys zalunfiban’s medical significance and potential benefits.
Provides science-driven investor materials, including downloadable reports and clinical trial data.
Showcases CeleCor as a leader in prehospital cardiac care innovation.
Ensures seamless navigation and accessibility across devices.

Scope

The project followed a structured, phased approach encompassing strategy, design, development, and ongoing support:

Website Development & UX Strategy

Designed a high-impact website tailored for a pharma/biotech audience.
Created detailed sitemaps, user flows, and wireframes to support investor engagement.
Developed a mobile-responsive site powered by a secure CMS for easy content updates.

Content & Branding

Produced investor decks and scientific storytelling assets to simplify complex concepts.
Designed mechanism-of-action visuals to communicate drug functionality.
Integrated an investor resource center with downloadable reports and data.

Development & Launch

Conducted full QA and cross-device testing to ensure a seamless experience.
Implemented SEO strategies to enhance visibility and discoverability.
Delivered final assets and trained the CeleCor team on CMS management.

Ongoing Support & Performance Tracking

Provided 12 months of technical maintenance and content updates.
Set up Google Analytics for engagement tracking and investor interest insights.

Results & Benefits

Investor-Ready Platform: The website now serves as CeleCor’s central channel for investor outreach and medical communication.
Simplified Scientific Storytelling: Complex medical data was made accessible and engaging for a diverse audience of stakeholders.
On-Time Delivery Through Agile Execution: The shift from waterfall to agile workflow enabled the team to adapt to delays and keep the project on track.
Future-Ready Infrastructure: The CMS-enabled platform ensures the site can evolve as CeleCor’s clinical research progresses.

This project highlighted the importance of adaptability, strategic communication, and a user-centered approach in delivering a high-impact digital presence for the biotech industry.